MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Cellular Biochemistry

• Publication date

  2015-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jcb.25162PMID 25802200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNAs in Breast Cancer: One More Turn in Regulation.

  2016cited by this paper
• MicroRNA profile in very young women with breast cancer

  2014cited by this paper
• High‐throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth

  2014cited by this paper
• MicroRNAs and cancer

  2014cited by this paper
• Functional Roles of microRNAs in Cancer: microRNomes and oncomiRs Connection

  2013cited by this paper
• Coordinated Targeting of the EGFR Signaling Axis by MicroRNA-27a*

  2013cited by this paper
• The miR-106b∼25 cluster promotes bypass of doxorubicin-induced senescence and increase in motility and invasion by targeting the E-cadherin transcriptional activator EP300

  2013cited by this paper
• The Function Role of miR-181a in Chemosensitivity to Adriamycin by Targeting Bcl-2 in Low-Invasive Breast Cancer Cells

  2013cited by this paper
• MicroRNA-Regulated Protein-Protein Interaction Networks and Their Functions in Breast Cancer

  2013cited by this paper
• Therapeutic potential of an anti-diabetic drug, metformin: alteration of miRNA expression in prostate cancer cells.

  2013cited by this paper
• Modulation of Cancer Traits by Tumor Suppressor microRNAs

  2013cited by this paper
• MiR-181 a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein ( BCRP / ABCG 2 )

  2013cited by this paper
• MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2)

  2013cited by this paper
• Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer

  2013cited by this paper
• MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.

  2013influential reference
• MicroRNA-21-3p, a Berberine-Induced miRNA, Directly Down-Regulates Human Methionine Adenosyltransferases 2A and 2B and Inhibits Hepatoma Cell Growth

  2013cited by this paper
• MicroRNAs and drug resistance of breast cancer: basic evidence and clinical applications

  2013cited by this paper
• MOLECULAR IMAGING OF GYNECOLOGICAL CANCERS : OVARIAN CANCER AS ROLE MODEL

  2012cited by this paper
• Adjuvant treatments for triple-negative breast cancers.

  2012influential reference
• MicroRNA‐195‐5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression

  2012cited by this paper
• Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer.

  2012cited by this paper
• Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer

  2012cited by this paper
• Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.

  2012cited by this paper
• Triple-negative breast cancer: epidemiological considerations and recommendations.

  2012cited by this paper
• DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways

  2012cited by this paper
• Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents.

  2012cited by this paper
• Emerging targeted therapies in triple-negative breast cancer.

  2012cited by this paper
• Differential Expression of miRNAs in Colorectal Cancer: Comparison of Paired Tumor Tissue and Adjacent Normal Mucosa Using High-Throughput Sequencing

  2012cited by this paper
• Contribution of MicroRNA-1275 to Claudin11 Protein Suppression via a Polycomb-mediated Silencing Mechanism in Human Glioma Stem-like Cells*

  2012cited by this paper
• MicroRNAs and breast cancer malignancy: An overview of miRNA-regulated cancer processes leading to metastasis

  2012cited by this paper
• miRNA-34a is associated with docetaxel resistance in human breast cancer cells

  2011cited by this paper
• 5‐fluorouracil drug alters the microrna expression profiles in MCF‐7 breast cancer cells

  2011cited by this paper
• Widespread regulatory activity of vertebrate microRNA* species.

  2011cited by this paper
• Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells.

  2011cited by this paper
• Adjuvant systemic treatment for individual patients with triple negative breast cancer.

  2011cited by this paper
• Translational Control of TOP2A Influences Doxorubicin Efficacy

  2011cited by this paper
• MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways

  2011cited by this paper
• Identification of microRNAs associated with tamoxifen resistance in breast cancer

  2011cited by this paper
• Directed therapy of subtypes of triple-negative breast cancer.

  2010cited by this paper
• Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin

  2010cited by this paper
• Treatment of triple negative breast cancer (TNBC): current options and future perspectives.

  2010influential reference
• Cancer esearch cular and Cellular Pathobiology miR-1792 Cluster of MicroRNAs Confers Tumorigenicity R nhibiting Oncogene-Induced Senescence

  2010cited by this paper
• Context-Dependent Bidirectional Regulation of the MutS Homolog 2 by Transforming Growth Factor β Contributes to Chemoresistance in Breast Cancer Cells

  2010cited by this paper
• Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells

  2010cited by this paper
• Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1.

  2010cited by this paper
• UC Office of the President Recent Work Title Context-dependent bidirectional regulation of the mutS homolog 2 by transforming growth factor β contributes to chemoresistance in breast cancer cells

  2010cited by this paper
• Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype

  2010cited by this paper
• MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.

  2010cited by this paper
• Alterations of microRNAs and their targets are associated with acquired resistance of MCF‐7 breast cancer cells to cisplatin

  2010cited by this paper
• Directed therapy of subtypes of triple-negative breast cancer.

  2010cited by this paper
• Downregulation of miR-21 Enhances Chemotherapeutic Effect of Taxol in Breast Carcinoma Cells

  2010cited by this paper
• MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression*

  2010cited by this paper
• MicroRNA 92a-2*: A Biomarker Predictive for Chemoresistance and Prognostic for Survival in Patients with Small Cell Lung Cancer

  2010cited by this paper
• Management of triple negative breast cancer.

  2010cited by this paper
• MicroRNAs as New Players for Diagnosis, Prognosis, and Therapeutic Targets in Breast Cancer

  2009cited by this paper
• MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents

  2009cited by this paper
• microRNA-205 regulates HER3 in human breast cancer.

  2009cited by this paper
• Pattern of metastatic spread in triple-negative breast cancer

  2009cited by this paper
• Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance

  2009cited by this paper
• Hyaluronan-CD44 Interaction with Protein Kinase Cϵ Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells*

  2009cited by this paper
• Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K.

  2009cited by this paper
• Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.

  2008influential reference
• Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin

  2008cited by this paper
• Endogenous human microRNAs that suppress breast cancer metastasis

  2008cited by this paper
• Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

  2008cited by this paper
• An Integrated Approach to the Prediction of Chemotherapeutic Response in Patients with Breast Cancer

  2008cited by this paper
• The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.

  2008cited by this paper
• MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1*♦

  2008cited by this paper
• MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer*

  2008cited by this paper
• Inhibition of the Canonical IKK/NFκB Pathway Sensitizes Human Cancer Cells to Doxorubicin

  2007cited by this paper
• The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes

  2007cited by this paper
• Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence

  2007cited by this paper
• microRNAs as oncogenes and tumor suppressors.

  2007cited by this paper
• MicroRNAs and cancer

  2007cited by this paper
• Inhibition of the canonical IKK/NF kappa B pathway sensitizes human cancer cells to doxorubicin.

  2007cited by this paper
• OncomiRs: the discovery and progress of microRNAs in cancers

  2007cited by this paper
• Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells.

  2006cited by this paper
• MicroRNA expression and function in cancer.

  2006cited by this paper
• The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays

  2006cited by this paper
• MicroRNAs as oncogenes and tumor suppressors.

  2005cited by this paper
• Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

  2005cited by this paper
• Computational identification of Drosophila microRNA genes

  2003cited by this paper
• Cáncer

  1939cited by this paper

• Time-Dependent Loss of miR-548c-3p and Activation of E2F3/FOXM1 in Breast Cancer: In Vitro and TCGA-Based Evidence for a Post-Transcriptional Mechanism

  2026cites this paper
• Ectopic expression of miR-34a/-328 sensitizes breast cancer stem cells to gamma rays/doxorubicin by BCL2/ABCG2 targeting

  2025cites this paper
• Direct detection of microRNA in liquid biopsies from single cancer spheroids

  2025cites this paper
• Insights into molecular mechanisms of chemotherapy resistance in cancer

  2024cites this paper
• The Overexpressed MicroRNAs miRs-182, 155, 493, 454, and U6 snRNA and Underexpressed let-7c, miR-328, and miR-451a as Potential Biomarkers in Invasive Breast Cancer and Their Clinicopathological Significance

  2024cites this paper
• Potential biomarkers in breast cancer drug development: application of the biomarker qualification evidentiary framework.

  2024cites this paper
• MiRNAs as Promising Therapeutic Targets for Breast Cancer

  2024cites this paper
• Novel Siglec-15-Sia axis inhibitor leads to colorectal cancer cell death by targeting miR-6715b-3p and oncogenes

  2023cites this paper
• The Role of miRNAs in the Resistance of Anthracyclines in Breast Cancer: A Systematic Review

  2022cites this paper
• miR-200c increases the sensitivity of breast cancer cells to Doxorubicin through downregulating MDR1 gene.

  2022cites this paper
• Identification of Gender- and Subtype-Specific Gene Expression Associated with Patient Survival in Low-Grade and Anaplastic Glioma in Connection with Steroid Signaling

  2022cites this paper
• Negative Regulation of ULK1 by microRNA-106a in Autophagy Induced by a Triple Drug Combination in Colorectal Cancer Cells In Vitro

  2021cites this paper
• Combination of Metformin, Sodium Oxamate and Doxorubicin Induces Apoptosis and Autophagy in Colorectal Cancer Cells via Downregulation HIF-1α

  2021cites this paper
• RETRACTED ARTICLE: The role of miRNAs and lncRNAs in conferring resistance to doxorubicin

  2021cites this paper
• miR-197-5p increases Doxorubicin-mediated anticancer cytotoxicity of HT1080 fibrosarcoma cells by decreasing drug efflux.

  2021cites this paper
• Breast cancer: Muscarinic receptors as new targets for tumor therapy

  2021cites this paper
• miRNA Expression Analysis: Cell Lines HCC1500 and HCC1937 as Models for Breast Cancer in Young Women and the miR-23a as a Poor Prognostic Biomarker

  2020cites this paper
• Large miRNA survival analysis reveals a prognostic four-biomarker signature for triple negative breast cancer

  2020cites this paper
• Major obstacles to doxorubicin therapy: Cardiotoxicity and drug resistance

  2020cites this paper
• MiR-548c-3p inhibits the proliferation, migration and invasion of human breast cancer cell by targeting E2F3

  2020cites this paper
• Differences of time-dependent microRNA expressions in breast cancer cells

  2020cites this paper
• The inhibitive effect of sh-hiF1a-as2 on the proliferation, invasion, and pathological damage of breast cancer via targeting mir-548c-3p through regulating hiF-1 α /VegF pathway in vitro and vivo

  2019cites this paper
• MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway.

  2019cites this paper
• The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors

  2019cites this paper
• The inhibitive effect of sh-HIF1A-AS2 on the proliferation, invasion, and pathological damage of breast cancer via targeting miR-548c-3p through regulating HIF-1α/VEGF pathway in vitro and vivo

  2019cites this paper
• Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung Adenocarcinoma

  2018cites this paper
• Increased expression of miR-155 and miR-222 is associated with lymph node positive status

  2018cites this paper
• MicroRNAs in triple-negative breast cancer.

  2018cites this paper
• Curcumin induces apoptotic cell death in human pancreatic cancer cells via the miR-340/XIAP signaling pathway.

  2017influential citation
• A microRNA signature associated with pathological complete response to novel neoadjuvant therapy regimen in triple-negative breast cancer

  2017cites this paper
• Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma

  2016cites this paper
• Current state of phenolic and terpenoidal dietary factors and natural products as non-coding RNA/microRNA modulators for improved cancer therapy and prevention

  2016cites this paper
• Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy.

  2016cites this paper
• Epigenetic alternations and cancer chemotherapy response

  2016cites this paper
• MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN

  2016cites this paper
• Comprehensive Expression Profiling and Functional Network Analysis of p53-Regulated MicroRNAs in HepG2 Cells Treated with Doxorubicin

  2016cites this paper
• The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer

  2016cites this paper
• Has-miR-30a regulates autophagic activity in cervical cancer upon hydroxycamptothecin exposure.

  2015cites this paper